| Q83172673 | 3-T MRI with phased-array surface coil in the local staging of rectal cancer |
| Q55231489 | A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases. |
| Q30495829 | A pre-post test evaluation of the impact of the PELICAN MDT-TME Development Programme on the working lives of colorectal cancer team members |
| Q56528295 | A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS |
| Q33517932 | APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling |
| Q90049483 | Accuracy of Endoscopic Ultrasound in Staging of Early Rectal Cancer |
| Q30884451 | Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data |
| Q57560962 | Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial |
| Q36025983 | Advances and challenges in treatment of locally advanced rectal cancer |
| Q38052458 | Advances in oncologic imaging: update on 5 common cancers |
| Q36325514 | An evaluation of four CT-MRI co-registration techniques for radiotherapy treatment planning of prone rectal cancer patients |
| Q33973332 | Application of endoscopic sonography in preoperative staging of rectal cancer: six-year experience |
| Q64237759 | Application of magnetic resonance diffusion kurtosis imaging for distinguishing histopathologic subtypes and grades of rectal carcinoma |
| Q86169023 | Are we denying distant control? A call for revising the treatment protocols of patients with ultra-low rectal cancer who potentially require abdominoperineal resection |
| Q34027974 | Assessing outcomes following surgery for colorectal cancer using quality of care indicators. |
| Q91752722 | Assessment of a Staging System for Sigmoid Colon Cancer Based on Tumor Deposits and Extramural Venous Invasion on Computed Tomography |
| Q34267122 | Assessment of response to chemoradiation therapy in rectal cancer using MR volumetry based on diffusion-weighted data sets: a preliminary report. |
| Q38198957 | Benign and malignant tumors of the rectum and perirectal region. |
| Q38943223 | Beyond Histologic Staging: Emerging Imaging Strategies in Colorectal Cancer with Special Focus on Magnetic Resonance Imaging |
| Q41564284 | Characteristics and Prognostic Significance of Preoperative Magnetic Resonance Imaging-Assessed Circumferential Margin in Rectal Cancer |
| Q37854733 | Chemoradiation therapy in the management of gastrointestinal malignancies |
| Q36086751 | Circulating proteins in response to combined-modality therapy in rectal cancer identified by antibody array screening |
| Q51152368 | Circumferential resection margin (CRM) positivity after MRI assessment and adjuvant treatment in 189 patients undergoing rectal cancer resection. |
| Q36949323 | Circumferential resection margin positivity after preoperative chemoradiotherapy based on magnetic resonance imaging for locally advanced rectal cancer: implication of boost radiotherapy to the involved mesorectal fascia |
| Q62638005 | Circumferential resection margins of rectal tumours post-radiotherapy: how can MRI aid surgical planning? |
| Q36820078 | Clarifying the TNM staging of rectal cancer in the context of modern imaging and neo-adjuvant treatment: 'y''u' and 'p' need 'mr' and 'ct'. |
| Q27005702 | Clinical application of multimodality imaging in radiotherapy treatment planning for rectal cancer |
| Q47728264 | Clinicopathological, genomic and immunological factors in colorectal cancer prognosis |
| Q92716402 | Colorectal Cancer in the Elderly Patient: The Role of Neo-adjuvant Therapy |
| Q55924124 | Colorectal cancer |
| Q37338957 | Combination of three-gene immunohistochemical panel and magnetic resonance imaging-detected extramural vascular invasion to assess prognosis in non-advanced rectal cancer patients |
| Q57088824 | Commentary: MRI should not predict histopathological involved margins |
| Q36325238 | Comparison of conventional and three-dimensional conformal CT planning techniques for preoperative chemoradiotherapy for locally advanced rectal cancer |
| Q43207493 | Comparison of magnetic resonance imaging-fluorodeoxy- glucose positron emission tomography fusion with pathological staging in rectal cancer. |
| Q37201832 | Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer |
| Q104468691 | Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry stu |
| Q34719568 | Could preoperative short-course radiotherapy be the treatment of choice for localized advanced rectal carcinoma? |
| Q85243851 | Criteria for three-dimensional anorectal ultrasound assessment of response to chemoradiotherapy in rectal cancer patients |
| Q27010257 | Current approaches and challenges for monitoring treatment response in colon and rectal cancer |
| Q38734893 | Current topics in the multimodality treatment of locally advanced rectal cancer |
| Q39771110 | Current trends in staging rectal cancer |
| Q47562422 | DNA hypermethylation as a predictor of extramural vascular invasion (EMVI) in rectal cancer. |
| Q56441469 | Defining the surgical planes on MRI improves surgery for cancer of the low rectum |
| Q62635773 | Defunctioning Stomas Result in Significantly More Short-Term Complications Following Low Anterior Resection for Rectal Cancer |
| Q36778768 | Detection of recurrent rectal cancer with CT, MRI and PET/CT. |
| Q40815241 | Determinants of survival following pelvic exenteration for primary rectal cancer. |
| Q37978211 | Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis |
| Q46599418 | Diffusion-weighted MR imaging in primary rectal cancer staging demonstrates but does not characterise lymph nodes. |
| Q52874057 | Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survival. |
| Q47568166 | Dosimetric evaluation of magnetic resonance-generated synthetic CT for radiation treatment of rectal cancer |
| Q53137607 | Early FDG PET response assessment of preoperative radiochemotherapy in locally advanced rectal cancer: correlation with long-term outcome. |
| Q34863354 | Effect of multidisciplinary team treatment on outcomes of patients with gastrointestinal malignancy |
| Q35766653 | Efficiency of Non-Contrast-Enhanced Liver Imaging Sequences Added to Initial Rectal MRI in Rectal Cancer Patients |
| Q37589565 | Essential Items for Structured Reporting of Rectal Cancer MRI: 2016 Consensus Recommendation from the Korean Society of Abdominal Radiology |
| Q99636197 | Evaluation of the Extent of Mesorectal Invasion and Mesorectal Fascia Involvement in Patients with T3 Rectal Cancer With 2-D and 3-D Transrectal Ultrasound: A Pilot Comparison Study With Magnetic Resonance Imaging Findings |
| Q38398872 | Evolution of imaging in rectal cancer: multimodality imaging with MDCT, MRI, and PET. |
| Q39390635 | Evolving role of neoadjuvant therapy in rectal cancer |
| Q37878381 | Extended abdominoperineal excision vs. standard abdominoperineal excision in rectal cancer--a systematic overview |
| Q37459563 | Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer |
| Q37016853 | Factors Associated With Oncologic Outcomes Following Abdominoperineal or Intersphincteric Resection in Patients Treated With Preoperative Chemoradiotherapy: A Propensity Score Analysis |
| Q57476378 | Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis |
| Q84231029 | Factors related to preoperative assessment of the circumferential resection margin and the extent of mesorectal invasion by magnetic resonance imaging in rectal cancer: a prospective comparison study |
| Q42130502 | Focusing the management of rectal cancer. |
| Q34101464 | Gastrointestinal imaging-practical magnetic resonance imaging approach |
| Q47366773 | Haralick's texture features for the prediction of response to therapy in colorectal cancer: a preliminary study |
| Q60912484 | Has the role of EUS in rectal cancer staging changed in the last decade? |
| Q64282678 | High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer |
| Q88923495 | Histopathological and radiological reporting in rectal cancer: concepts and controversies, facts and fantasies |
| Q52842219 | Histopathological work-up of resection specimens, local excisions and biopsies in colorectal cancer. |
| Q48127728 | How Is Rectal Cancer Managed: a Survey Exploring Current Practice Patterns in Canada. |
| Q49564144 | How Should Imaging Direct/Orient Management of Rectal Cancer? |
| Q28075896 | Imaging Advances in Colorectal Cancer |
| Q37017113 | Imaging and management of rectal cancer |
| Q89402906 | Imaging biomarkers in oncology: Basics and application to MRI |
| Q90736709 | Imaging of rectal cancer |
| Q30436760 | Imaging paradigms in assessment of rectal carcinoma: loco-regional and distant staging |
| Q38812176 | Importance of surgical margins in rectal cancer |
| Q89470941 | Improving quality of care and clinical outcomes for rectal cancer through clinical audits in a multicentre cancer care organisation |
| Q41849102 | Intersphincteric resection for low rectal cancer: an overview |
| Q38207015 | Interval to surgery after neoadjuvant treatment for colorectal cancer |
| Q85219462 | Intra-operative perforation is an important predictor of local recurrence and impaired survival after abdominoperineal resection for rectal cancer |
| Q51166045 | Laparoscopic extraperitoneal rectal cancer surgery: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). |
| Q89463418 | Laparoscopic surgery for rectal cancer: the verdict is not final yet! |
| Q84010868 | Laparoscopic total mesorectal excision following long course chemoradiotherapy for locally advanced rectal cancer |
| Q37074149 | Local excision and transanal endoscopic microsurgery in the management of rectal cancer with a focus on early carcinoma |
| Q37867593 | Local staging of rectal cancer: a review of imaging. |
| Q50095563 | Locally Advanced Disease and Pelvic Exenterations |
| Q37895253 | Locally advanced rectal cancer: a comparison of management strategies |
| Q28072618 | Locally advanced rectal cancer: management challenges |
| Q91646263 | Long Term Results of Modified Intersphincteric Resections for Low Rectal Cancer: A Single Center Experience |
| Q55285345 | Long-term oncological outcomes of local excision versus radical resection for early colorectal cancer in young patients without preoperative chemoradiotherapy: a population-based propensity matching study. |
| Q38222387 | MR imaging for rectal cancer: the role in staging the primary and response to neoadjuvant therapy |
| Q62104239 | MR imaging of rectal cancer before and after chemoradiation therapy |
| Q39869907 | MR vs CT imaging: low rectal cancer tumour delineation for three-dimensional conformal radiotherapy |
| Q56441363 | MRI Predictive Factors for Long-Term Outcomes of Low Rectal Tumours |
| Q38692801 | MRI assessment and outcomes in patients receiving neoadjuvant chemotherapy only for primary rectal cancer: long-term results from the GEMCAD 0801 trial. |
| Q48290692 | MRI can be used to assess advanced T-stage colon carcinoma as well as rectal carcinoma |
| Q90605355 | MRI evaluation of extramural vascular invasion by inexperienced radiologists |
| Q30998504 | MRI for Assessing Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer Using DCE-MR and DW-MR Data Sets: A Preliminary Report |
| Q38198858 | MRI for assessing and predicting response to neoadjuvant treatment in rectal cancer. |
| Q34663079 | MRI in local staging of rectal cancer: an update |
| Q43241104 | MRI in predicting curative resection of rectal cancer: defining a "window of opportunity" for laparoscopic surgery |
| Q43241070 | MRI in predicting curative resection of rectal cancer: does post-neoadjuvant MRI have a role? |
| Q43241115 | MRI in predicting curative resection of rectal cancer: new dilemma in multidisciplinary team management |
| Q39616237 | MRI rectal cancer in Australia and New Zealand: An audit from the PETACC-6 trial |
| Q56441511 | MRI staging of low rectal cancer |
| Q36235746 | MRI volumetry for prediction of tumour response to neoadjuvant chemotherapy followed by chemoradiotherapy in locally advanced rectal cancer |
| Q57088783 | MRI-Based Assessment of Tumor Regression in Rectal Cancer |
| Q58028708 | MRI-Based Indications for Neoadjuvant Radiochemotherapy in Rectal Carcinoma: Interim Results of a Prospective Multicenter Observational Study |
| Q38134007 | MRI-based treatment of rectal cancer: is prognostication of the recurrence risk solid enough to render radiation redundant? |
| Q59115806 | MRI-detected extramural vascular invasion is an independent prognostic factor for synchronous metastasis in patients with rectal cancer |
| Q83945587 | Macroscopic assessment of mesorectal excision in rectal cancer: a useful tool for improving quality control in a multidisciplinary team |
| Q48276189 | Magnetic Resonance Imaging-Detected Extramural Venous Invasion in Rectal Cancer before and after Preoperative Chemoradiotherapy: Diagnostic Performance and Prognostic Significance. |
| Q35675792 | Magnetic resonance imaging (MRI) in rectal cancer: a comprehensive review |
| Q52917042 | Magnetic resonance imaging (MRI)-based indication for neoadjuvant treatment of rectal carcinoma and the surrogate endpoint CRM status. |
| Q35005141 | Magnetic resonance imaging and endorectal ultrasound for diagnosis of rectal lesions |
| Q44679582 | Magnetic resonance imaging in rectal cancer downstaged using neoadjuvant chemoradiation: accuracy of prediction of tumour stage and circumferential resection margin status |
| Q27027906 | Magnetic resonance imaging in rectal cancer: a surgeon's perspective |
| Q38373205 | Magnetic resonance imaging of rectal cancer: staging and restaging evaluation |
| Q47554549 | Magnetic resonance tumor regression grade (MR-TRG) to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer |
| Q37987203 | Meta-analysis of survival based on resection margin status following surgery for recurrent rectal cancer |
| Q48170193 | Meta-analysis of the impact of surgical approach on the grade of mesorectal excision in rectal cancer |
| Q37820756 | Multidisciplinary management in rectal cancer |
| Q38123983 | Multidisciplinary management of rectal cancer: the OSTRICH. |
| Q37578503 | Multidisciplinary treatment of resectable rectal cancer |
| Q26992282 | Multimodal imaging evaluation in staging of rectal cancer |
| Q38216889 | National and international guidelines for rectal cancer |
| Q39172475 | Neoadjuvant Treatment for Locally Advanced Rectal Cancer: New Concepts in Clinical Trial Design |
| Q39906058 | Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial |
| Q26796352 | Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer |
| Q55710885 | Neoadjuvant chemoradiotherapy of the rectal carcinoma - The correlation between the findings on the restaging multiparametric 3T MRI scanning and the surgical findings. |
| Q27003878 | Neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer |
| Q90205928 | Neoadjuvant radiotherapy for rectal cancer management |
| Q35687452 | Neoadjuvant treatment in rectal cancer: actual status |
| Q37158143 | Neoadjuvant treatment of rectal cancer: where are we now? |
| Q91638993 | Neoadjuvant treatments for resectable rectal cancer: A network meta-analysis |
| Q36871507 | Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer |
| Q39399021 | Oncological results of extended resection for locally advanced rectal cancer: the value of postirradiation MRI in predicting local recurrence. |
| Q44326705 | One millimetre is the safe cut-off for magnetic resonance imaging prediction of surgical margin status in rectal cancer. |
| Q26743853 | Optimal Imaging Strategies for Rectal Cancer Staging and Ongoing Management |
| Q26827660 | Optimal imaging staging of rectal cancer |
| Q49087598 | Outcome for stage II and III rectal and colon cancer equally good after treatment improvement over three decades |
| Q46793935 | Outcome of abdominosacral resection for locally advanced primary and recurrent rectal cancer |
| Q38137817 | Pathology is a necessary and informative tool in oncology clinical trials. |
| Q60046001 | Pelvic exenterations for primary rectal cancer: Analysis from a 10-year national prospective database |
| Q53114667 | Potentials of high resolution magnetic resonance imaging versus computed tomography for preoperative local staging of colon cancer. |
| Q44571301 | Practicability of quality goals for the treatment of rectal cancer |
| Q24202425 | Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer |
| Q38827538 | Pre-operative staging of rectal cancer: a review of imaging techniques |
| Q39277599 | Predicting response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer with serum biomarkers. |
| Q37628501 | Predictors of circumferential resection margin involvement in surgically resected rectal cancer: A retrospective review of 23,464 patients in the US National Cancer Database |
| Q83292305 | Preoperative chemoradiation may not always be needed for patients with T3 and T2N+ rectal cancer |
| Q24200568 | Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer |
| Q24241258 | Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer |
| Q37345327 | Preoperative downstaging chemoradiation with concurrent irinotecan and capecitabine in MRI-defined locally advanced rectal cancer: a phase I trial (NWCOG-2). |
| Q82464469 | Preoperative evaluation of the depth of anal canal invasion in very low rectal cancer by magnetic resonance imaging and surgical indications for intersphincteric resection |
| Q36610647 | Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer |
| Q37680997 | Preoperative radiotherapy in rectal signet-ring cell carcinoma - magnetic resonance imaging and treatment outcome: Report of six cases |
| Q37158196 | Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. |
| Q43241080 | Preoperative staging for rectal cancer |
| Q57088862 | Preoperative staging of rectal cancer |
| Q36537952 | Pretreatment high-resolution rectal MRI and treatment response to neoadjuvant chemoradiation |
| Q48178383 | Primary Rectal Cancer: Repeatability of Global and Local-Regional MR Imaging Texture Features. |
| Q34256424 | Proforma-based reporting in rectal cancer |
| Q53208805 | Prognostic significance of a preoperative magnetic resonance imaging assessment of the distance of mesorectal extension in clinical T3 lower rectal cancer. |
| Q39554319 | Progress in rectal cancer treatment. |
| Q54152072 | Prospective randomized trial of neoadjuvant chemotherapy during the 'wait period' following preoperative chemoradiotherapy for rectal cancer: results of the WAIT trial. |
| Q26998562 | Quality assurance in the treatment of colorectal cancer: the EURECCA initiative |
| Q90950519 | Radiomics features on radiotherapy treatment planning CT can predict patient survival in locally advanced rectal cancer patients |
| Q38971355 | Re-Staging Following Long-Course Chemoradiotherapy For Rectal Cancer: Does It Influence Management? |
| Q39424695 | Recent advances in the management of rectal cancer: No surgery, minimal surgery or minimally invasive surgery |
| Q37962660 | Recommendations and expert opinion on the treatment of locally advanced rectal cancer in Spain. |
| Q50095256 | Rectal cancer confined to the bowel wall: the role of 3 Tesla phased-array MR imaging in T categorization. |
| Q89922476 | Rectal cancer staging using MRI: adherence in reporting to evidence-based practice |
| Q37034524 | Rectal cancer staging: focus on the prognostic significance of the findings described by high-resolution magnetic resonance imaging |
| Q37822738 | Rectal cancer staging: is there an optimal method? |
| Q84211615 | Rectal cancer--the times they are a-changing |
| Q84789520 | Rectal cancer: quo vadis, neoadjuvant and adjuvant (chemo) radiotherapy? |
| Q38021755 | Rectal imaging: part 1, High-resolution MRI of carcinoma of the rectum at 3 T. |
| Q42642902 | Regional lymph node metastasis and locoregional recurrence of rectal carcinoma in the era of TME [corrected] surgery. Implications for treatment decisions |
| Q44442248 | Relevance of magnetic resonance imaging-detected pelvic sidewall lymph node involvement in rectal cancer |
| Q91599628 | Response Assessment with MRI after Chemoradiotherapy in Rectal Cancer: Current Evidences |
| Q64242805 | Response evaluation after neoadjuvant treatment for rectal cancer using modern MR imaging: a pictorial review |
| Q26824040 | Role of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography in gastrointestinal cancers |
| Q41063995 | Routine pelvic MRI using phased-array coil for detection of extraprostatic tumour extension: accuracy and clinical significance |
| Q26743883 | Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer |
| Q37038486 | Selecting patients with locally advanced rectal cancer for neoadjuvant treatment strategies |
| Q35687645 | Selection criteria for the radical treatment of locally advanced rectal cancer |
| Q38001344 | Shifting concepts in rectal cancer management: a review of contemporary primary rectal cancer treatment strategies |
| Q35584916 | Short-course versus standard chemoradiation in T3 rectal cancer |
| Q41786275 | Staging rectal cancer: endoscopic ultrasound and pelvic MRI. |
| Q35545704 | Standard versus extralevator abdominoperineal low rectal cancer excision outcomes: a systematic review and meta-analysis. |
| Q91846459 | Standardised reports with a template format are superior to free text reports: the case for rectal cancer reporting in clinical practice |
| Q90644219 | State of the Art - Rectal Cancer Surgery |
| Q35181100 | Successful downstaging of high rectal and recto-sigmoid cancer by neo-adjuvant chemo-radiotherapy |
| Q38780368 | Surveillance after curative treatment for colorectal cancer |
| Q38428481 | Systematic review and meta-analysis of the accuracy of MRI and endorectal ultrasound in the restaging and response assessment of rectal cancer following neoadjuvant therapy |
| Q38113863 | Tailored rectal cancer treatment--a time for implementing contemporary prognostic factors? |
| Q89505021 | The Canadian Partnership Against Cancer Rectal Cancer Project: Protocol for a Pan-Canadian, Multidisciplinary Quality Improvement Initiative to Optimize the Quality of Rectal Cancer Care |
| Q49564131 | The Perfect Total Mesorectal Excision Obviates the Need for Anything Else in the Management of Most Rectal Cancers |
| Q37730979 | The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal Cancer |
| Q36800256 | The accuracy of Multi-detector row CT for the assessment of tumor invasion of the mesorectal fascia in primary rectal cancer |
| Q86808797 | The anthropometric definition of the rectum is highly variable |
| Q44598569 | The impact of the two-week wait referral pathway on rectal cancer survival |
| Q89060391 | The influence of endorectal filling on rectal cancer staging with MRI |
| Q90591161 | The multidisciplinary management of rectal cancer |
| Q37751543 | The role of the pathologist in rectal cancer diagnosis and staging and surgical quality assessment |
| Q47659304 | The selection process can improve the outcome in locally advanced and recurrent colorectal cancer: activity and results of a dedicated multidisciplinary colorectal cancer centre. |
| Q37419408 | The use of endoscopic ultrasonography and other imaging modalities in the preoperative staging of rectal villous tumours: a case of overstaging by magnetic resonance imaging |
| Q92708708 | The value of biomarkers in colorectal cancer: Protocol for an overview and a secondary analysis of systematic reviews of diagnostic test accuracy |
| Q53258574 | The value of true axial imaging for CT staging of colonic cancer |
| Q41958603 | Time to Redefine the Role of Routine Combined-Modality Therapy for Invasive Stage-II/III Rectal Cancer? |
| Q36974695 | Total mesorectal excision and management of rectal cancer. |
| Q38247507 | Total mesorectal excision optimized by pelvic MRI. |
| Q92189101 | Total neoadjuvant therapy in locally advanced rectal cancer: Role of systemic chemotherapy |
| Q37998384 | Toward the non-surgical management of locally advanced rectal cancer |
| Q57778679 | Transrectal ultrasonography and magnetic resonance imaging in the staging of rectal cancer. Effect of experience |
| Q27010573 | Transrectal ultrasonography of anorectal diseases: advantages and disadvantages. |
| Q36351882 | Treatment of locally advanced rectal cancer: controversies and questions |
| Q38170032 | Treatment of stage II-III rectal cancer patients |
| Q35555993 | Tumor regression in rectal cancer after intensified neoadjuvant chemoradiation: a morphometric and clinicopathological study. |
| Q35206160 | Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases |
| Q48106528 | Use of Preoperative Magnetic Resonance Imaging to Select Patients with Rectal Cancer for Neoadjuvant Chemoradiation--Interim Analysis of the German OCUM Trial (NCT01325649). |
| Q50107749 | Utilisation of specialist care in patients with incurable rectal cancer. a population-based study from Western Norway |
| Q53086539 | Value of diffusion-weighted and gadolinium-enhanced MRI for the diagnosis of pelvic recurrence from colorectal cancer. |
| Q36343876 | Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging |
| Q55077052 | Watch-and-Wait as a Therapeutic Strategy in Rectal Cancer. |
| Q45006735 | What is the incidence of metastatic lymph node involvement after significant pathologic response of primary tumor following neoadjuvant treatment for locally advanced rectal cancer? |
| Q38877730 | Whole-body PET/MRI for colorectal cancer staging: Is it the way forward? |
| Q80595783 | [MR-endoscopic US correlation for loco-regional staging of rectal carcinoma] |
| Q53476196 | [Preoperative staging of rectal cancer]. |
| Q84197328 | [Rectal cancer - local staging and imaging under neoadjuvant therapy] |
| Q84344633 | [The role of magnetic resonance imaging to select patients for preoperative treatment in rectal cancer] |